Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapy

Coronary Artery Calcium-Guided Antiplatelet Therapy: What Does the Evidence Show?

The American journal of medicine·2026

Advancing cancer therapeutics: new perspectives on mechanisms, regulatory and policy challenges, and innovative multi-modality strategies for the early detection of cardiotoxicity.

Journal of thrombosis and thrombolysis·2026

Clinical spectrum and mechanistic insights into cardiotoxicity from cancer therapies.

Journal of thrombosis and thrombolysis·2026

Innovative strategies for early detection of cardiotoxicity: artificial intelligence and multi-modality collaborative models.

Journal of thrombosis and thrombolysis·2026

Regulatory challenges and current policy for cardiotoxicity detection in oncology drug development.

Journal of thrombosis and thrombolysis·2026

250 years of medicine and democracy in America.

The American journal of medicine·2026

Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials.

Journal of thrombosis and thrombolysis·2026

Direct oral anticoagulant dose vs dual antiplatelet therapy after left atrial appendage closure in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis.

Journal of thrombosis and thrombolysis·2026

Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study.

Journal of thrombosis and thrombolysis·2026

Admission electrocardiographic markers of atrial cardiomyopathy predict persistent pulmonary hypertension and chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a retrospective cohort study.

Journal of thrombosis and thrombolysis·2026

Regulated cell death-induced coagulation dysfunction in sepsis.

Journal of thrombosis and thrombolysis·2026

Thrombomodulin Gly430Ser mutation attenuates the affinity with thrombin and contributes to thrombosis development.

Journal of thrombosis and thrombolysis·2026

Lathyrol Targets G6PD to Disrupt Redox Homeostasis in Non-Small Cell Lung Cancer.

ACS omega·2026

Comparative Treatment Outcomes Across Actionable Genomic Alterations in NSCLC: A Large Multicenter Real-World Study.

JTO clinical and research reports·2026

Development and Characterization of a Patient-Derived KIF5B-RET Fusion Lung Adenocarcinoma Cell Line for Subcutaneous and Central Nervous System Tumor Models in Immunodeficient Mice.

JTO clinical and research reports·2026

Use of the Behavioral Dyscontrol Scale-2 (BDS-2) to measure executive dysfunction in FXTAS.

Frontiers in molecular neuroscience·2026

Targeted niosomes protect the heart from doxorubicin-induced injury: evidence from oxidative stress, pyroptosis, and apoptosis pathways.

3 Biotech·2026

From dual inhibition to precision selectivity: the molecular rationale and clinical evolution of next-generation PARP1-selective inhibitors in solid tumors.

Frontiers in oncology·2026

Related Experiment Videos

Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapy

Related Concept Videos

Coronary Artery Calcium-Guided Antiplatelet Therapy: What Does the Evidence Show?

Advancing cancer therapeutics: new perspectives on mechanisms, regulatory and policy challenges, and innovative multi-modality strategies for the early detection of cardiotoxicity.

Clinical spectrum and mechanistic insights into cardiotoxicity from cancer therapies.

Innovative strategies for early detection of cardiotoxicity: artificial intelligence and multi-modality collaborative models.

Regulatory challenges and current policy for cardiotoxicity detection in oncology drug development.

250 years of medicine and democracy in America.

Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials.

Direct oral anticoagulant dose vs dual antiplatelet therapy after left atrial appendage closure in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis.

Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study.

Admission electrocardiographic markers of atrial cardiomyopathy predict persistent pulmonary hypertension and chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a retrospective cohort study.

Regulated cell death-induced coagulation dysfunction in sepsis.

Thrombomodulin Gly430Ser mutation attenuates the affinity with thrombin and contributes to thrombosis development.

Lathyrol Targets G6PD to Disrupt Redox Homeostasis in Non-Small Cell Lung Cancer.

Comparative Treatment Outcomes Across Actionable Genomic Alterations in NSCLC: A Large Multicenter Real-World Study.

Development and Characterization of a Patient-Derived KIF5B-RET Fusion Lung Adenocarcinoma Cell Line for Subcutaneous and Central Nervous System Tumor Models in Immunodeficient Mice.

Use of the Behavioral Dyscontrol Scale-2 (BDS-2) to measure executive dysfunction in FXTAS.

Targeted niosomes protect the heart from doxorubicin-induced injury: evidence from oxidative stress, pyroptosis, and apoptosis pathways.

From dual inhibition to precision selectivity: the molecular rationale and clinical evolution of next-generation PARP1-selective inhibitors in solid tumors.

Related Experiment Videos

Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapy

Related Concept Videos

Related Articles